GSK's Tafinlar named as FDA breakthrough therapy for lung cancer

[riky]

GSK's Tafinlar named as FDA breakthrough therapy for lung cancer

<p><a href="http://news.yahoo.com/gsk-39-tafinlar-named-fda-breakthrough-therapy-lung-154229466--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/lyzkSI274ESOnGUoEexCtw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-01-13T154229Z_1_CBREA0C17MV00_RTROPTP_2_GSK-CHINA.JPG" width="130" height="86" alt="The logo of GlaxoSmithKline is seen on its office building in Shanghai" align="left" title="The logo of GlaxoSmithKline is seen on its office building in Shanghai" border="0" /></a>LONDON (Reuters) - British pharmaceutical company GlaxoSmithKline said its Tafinlar cancer treatment had been given FDA breakthrough therapy designation for lung cancer, meaning the drug will be fast-tracked within the U.S. regulatory system. GSK said that Tafinlar, also known as dabrafenib, was designated an FDA breakthrough therapy on Monday following interim results from an ongoing Phase II study. Tafinlar is already approved for melanoma, the deadliest form of skin cancer. (Reporting by Sarah Young, Editing by Paul Sandle)</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login